✦ LIBER ✦

Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation

✍ Scribed by Giulio Metro; R. Chiari; M. Mare; D. Giannarelli; F. R. Tofanetti; V. Minotti; M. Ferraldeschi; D. Giuffrida; L. Marcomigni; C. Bennati; M. J. Fischer; M. Meacci; R. Bellavita; L. Pistola; V. Ludovini; L. Crinò

Publisher: Springer
Year: 2011
Tongue: English
Weight: 316 KB
Volume: 68
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-011-1632-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose escalation study of irinotecan comb

Dose escalation study of irinotecan combined with carboplatin for advanced non-small-cell lung cancer

✍ Koji Takeda; Shunichi Negoro; Nobuhide Takifuji; Takashi Nitta; Naruo Yoshimura; 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 77 KB

Gemcitabine plus carboplatin used as ind

Gemcitabine plus carboplatin used as induction regimen for elderly patients with locally advanced unresectable non-small cell lung cancer

✍ Zhihua Sun; Hongmin Zheng; Linyun Zhang 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 190 KB

A phase II study of paclitaxel plus cisp

A phase II study of paclitaxel plus cisplatin for advanced non-small-cell lung cancer in Japanese patients

✍ Hiroshi Sakai; Shuichi Yoneda; Tomohide Tamura; Yutaka Nishiwaki; Akira Yokoyama 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 77 KB

A phase I pharmacokinetic study of bexar

A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)

✍ Jordi Rodon; Charlotte D. Jacobs; Quincy Chu; Eric K. Rowinsky; Arturo Lopez-Ana 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 277 KB

Phase II trial of a 2-h infusion of gemc

Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer

✍ N. Xu; P. Shen; X. C. Zhang; L. F. Yu; H. Y. Bao; G. M. Shi; S. Huang; J. Chen; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 302 KB

Gemcitabine plus docetaxel as first-line

Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB